CymaBay Therapeutics, Inc.
Символ: CBAY
NASDAQ
32.48
USDПазарна цена днес
-32.9591
Съотношение P/E
-0.4773
Коефициент PEG
3.73B
MRK Cap
- 0.00%
Доходност на DIV
CymaBay Therapeutics, Inc. Структура на управлението
Информация за управлението
Име | Заглавие |
---|---|
Mr. Harish Shantharam C.F.A. | Chief Financial Officer, Principal Accounting & Financial Officer |
Ms. Becki Filice | Senior Vice President of Portfolio & Product Leadership |
Mr. Paul T. Quinlan | General Counsel, Chief Compliance Officer & Corporate Secretary |
Dr. Charles A. McWherter Ph.D. | President of Research & Development and Chief Scientific Officer |
Dr. Robert L. Martin | Senior Vice President of Manufacturing & Nonclinical Development |
Ms. Klara A. Dickinson-Eason | Chief Regulatory & Quality Assurance Officer |
Mr. Patrick J. O'Mara | Senior Vice President of Business Development |
Mr. Ben Kozub | Head of Commercial |
Mr. Ken Boehm | Senior Vice President of Human Resources |
Mr. Sujal A. Shah | President, Chief Executive Officer & Director |
Подобни акции
Може да се интересувате и от:CMRA
Топ мениджмънт:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
T5O.DE
Топ мениджмънт:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
PPBT
Топ мениджмънт:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...
SPHRF
Топ мениджмънт:
- Ms. Cheryl Maley...
- Mr. Justin Cahill
ARQT
Топ мениджмънт:
- Ms. Courtney Barton
- Ms. Ayisha Jeter
- Ms. Amanda Sheldon
ADTX
Топ мениджмънт:
- Mr. Ge Chen M.D....
- Dr. Dolly B. Tyan...
- Ms. Jennifer Lee